KLRG1 Cell Depletion As A Novel Therapeutic Strategy In Patients With Mature T-cell lymphoma Subtypes

CONCLUSIONS: Our findings suggest the potential benefit of a broader treatment strategy combining therapeutic antibodies with PI3Ki for the treatment of patients with mature T-cell and NK-cell neoplasms.PMID:38252421 | DOI:10.1158/1078-0432.CCR-23-3504

Source: Clinical Cancer Research - January 22, 2024 Category: Cancer & Oncology Authors: Bimarzhan Assatova Robert Willim Christopher Trevisani Garrett Haskett Khyati Maulik Kariya Kusha Chopra Sung Rye Park Michael Yevgeniy Tolstorukov Sean M McCabe Jessica Duffy Abner Louissaint Jani Huuhtanen Dipabarna Bhattacharya Satu Mustjoki Min Jung K Source Type: research